Liquid fiducial marker applicability in proton therapy of locally advanced lung cancer.
Scherman Rydhög J, Perrin R, Jølck RI, Gagnon-Moisan F, Larsen KR, Clementsen P, Riisgaard de Blanck S, Fredberg Persson G, Weber DC, Lomax T, Andresen TL, Munck Af Rosenschold P.
Scherman Rydhög J, et al.
Radiother Oncol. 2017 Mar;122(3):393-399. doi: 10.1016/j.radonc.2016.12.027. Epub 2017 Jan 16.
Radiother Oncol. 2017.
PMID: 28104299